We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Latest News

News

Beckman Coulter Collaborates in Multisite Research Project for Cardiovascular Disease Markers

The collaborative research will seek to discover genetic signatures for cardiovascular disease and obesity-related hypertension.
News

AVEO Pharmaceuticals and Lilly Sign Collaboration for Clinical Drug Response Project

Agreement highlights growing interest in novel biology platform that identifies clinical response of cancer drugs.
News

Buck Institute and Neurobiological Technologies Partner to Develop Treatment for Huntington's Disease

The research involves fibroblast growth factor-2 (FGF-2), a naturally occurring protein that has been studied extensively for its neuroprotective properties.
News

IPSOGEN to Undertake Pilot Study on JAK2 Cancer Biomarker with Astrazeneca

The pilot agreement with AstraZeneca to evaluate molecular services and products in cancer research.
News

Vermillion Announces Issuance of U.S. Patent Covering Method for Aiding Diagnosis of Kidney Disorder

The U.S. Patent office has issued Vermillion U.S. Patent No. 7,297,556 for aiding diagnosis of nephrotic syndrome.
News

ImmunoCellular Therapeutics Agrees to Acquire Molecular Antibody Technology

ImmunoCellular has entered into an agreement with Molecular Discoveries covering the IMUC’s acquisition of all monoclonal antibody related technology owned by MDC.
News

Gamma Medica-Ideas and Mayo Clinic Collaborate on new Breast Cancer Research Project

Multi-site clinical trial to study GM-I’s LumaGEM® Molecular Breast Imaging (MBI) technology for early detection, diagnosis and treatment of breast cancer.
News

Beckman Coulter to Acquire Flow Cytometry Instrumentation Business from Dako

Beckman Coulter will acquire Dako's research flow cytometry instrumentation business, which is based in Fort Collins, Colorado.
News

New Targeted Approach to Light-Activated Cancer Drugs

Combining light-activated cancer drugs with tumor-seeking antibodies could provide a more effective way of treating many cancers, according to new research.
News

Helicos BioSciences Joins Personalized Medicine Coalition

Helicos BioSciences Corporation has joined an educational and advocacy group dedicated to advancing the understanding and adoption of personalized medicine.
Advertisement